This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sugiura, K. Search for Related Content PubMed Articles by Sugiura, K.

Frozen Storage of 34 Various Solid and Ascites Tumors^*

( Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, N.Y.)

A variety of transplantable mouse, rat, hamster, and chicken tumors have been successfully stored at –76° C. (dry-ice chest) for a period of 1 year. These tumors are seven sarcomas, a mammary carcinoma, a skin carcinoma, a bladder carcinoma, a lung carcinoma, two lymphosarcomas, a glioma, a leukemia, a virus leukemia, a pancreatic tumor, and a small intestine tumor. Transplantability of a majority of mammary-type tumors was greatly damaged by frozen storage at –76° C. Transplantability of very slowly growing tumors—namely, Harding-Passey melanoma, Andervont hepatoma, Iglesias functional ovarian tumor, and Iglesias functional adrenal tumor—was either completely or almost completely abolished by frozen storage at –76° C. for 3 months.

The viability of Ridgway osteogenic sarcoma was completely destroyed by frozen storage for 1 month at –76° C. Transplantability of Wagner osteogenic sarcoma was markedly reduced following storage at –76° C. The viability of Ridgway osteogenic sarcoma was almost completely destroyed by frozen storage for 1 day at –76° C. or –25° C. Maintenance of this tumor for 1 day at 4°–5° C. did not alter its transplantability. Hauschka's slow freezing technic (from 0° C. to –25° C.) of neoplastic tissues appears to be less harmful to the viability of frozen tumor (Ridgway osteogenic sarcoma) than the technic of freezing described in the present report.

^* This investigation was supported by a grant from the American Cancer Society and by a Contract SA-43-ph-2445, National Institutes of Health, Cancer Chemotherapy National Service Center.

Received 9/13/60.